A

Armata Pharmaceuticals Inc
F:TG1N

Watchlist Manager
Armata Pharmaceuticals Inc
F:TG1N
Watchlist
Price: 5.5 EUR 3.77% Market Closed
Market Cap: 198.8m EUR

Wall Street
Price Targets

TG1N Price Targets Summary
Armata Pharmaceuticals Inc

Wall Street analysts forecast TG1N stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TG1N is 7.8 EUR with a low forecast of 7.73 EUR and a high forecast of 8.03 EUR.

Lowest
Price Target
7.73 EUR
41% Upside
Average
Price Target
7.8 EUR
42% Upside
Highest
Price Target
8.03 EUR
46% Upside
Armata Pharmaceuticals Inc Competitors:
Price Targets
COYA
Coya Therapeutics Inc
196% Upside
BNTX
BioNTech SE
46% Upside
6628
Transcenta Holding Limited
606% Upside
CYTK
Cytokinetics Inc
36% Upside
ADCT
ADC Therapeutics SA
133% Upside
145020
Hugel Inc
58% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
34% Upside

Revenue
Forecast

Revenue Estimate
Armata Pharmaceuticals Inc

For the last 12 years the compound annual growth rate for Armata Pharmaceuticals Inc's revenue is 19%.

19%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Armata Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Armata Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TG1N's stock price target?
Price Target
7.8 EUR

According to Wall Street analysts, the average 1-year price target for TG1N is 7.8 EUR with a low forecast of 7.73 EUR and a high forecast of 8.03 EUR.

Back to Top